1Gadducci A, Landoni F, Sartori E, et al. Uterine leiomyosarcoma:analysis of treatment failures and survival. Gynecol Oncol, 1996, 62:25-32.
2Giuntoli RL 2nd, Metzinger DS, DiMarco CS, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol,2003, 89(3): 460--469.
3Lissoni A, Cormio G, Bonazzi C, et al. Fertility-sparing surgery in uterine leiomyosareoma. Gyneeol Oncol, 1998, 70:348-350.
4Goff BA, Rice LW, Fleischhacker D, et al. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol, 1993, 50:105-109.
5Leitao MM, Sonoda Y, Brennan MF, et al. Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol, 2003, 91(1): 209-212.
6Sutton G, Blessing JA, Malfetano JH, et al. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a GOG study. Gynecol Oncol, 1996, 62:226-229.
7Currie LJ, Blessing JA, Muss HB, et al. Combination chemotherapy with hydroxyurea, dacarbazine, and etoposide in the treatment of uterine leiomyosarcoma: a GOG study. Gynecol Oncol, 1996, 62:27-30.
8Thigpen JT, Blessing JA, Wibanks GD. Cisplatin as second-line chemotherapy in the treatment of advanced or recurrent leiomyosarcoma of the uterus. Am J Clin Oncol, 1986, 9:18-20.
9Thigpen JT, Blessing JA, Beecham J, et al. Phase II trial of eisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a GOG study. J Clin Oneol, 1991, 9: 1962-1966.
10Sutton G, Blessing JA, Ball H. Phase Ⅱ trial of paelitaxel in leiomyosarcoma of the uterus: a GOG study. Gynecol Oncol, 1999,74:346-349.
